Prevention and therapy of serous otitis media by oral decongestant: a double-blind study in pediatric practice.

Abstract

We studied the efficacy of (1) preventing the development of serous otitis media (SOM) by using an oral decongestant in children with acute otitis media and (2) treating SOM with an oral decongestant. In a randomized double-blind study, 190 children were treated for acute otitis media with antibiotics and either pseudoephedrine hydrochloride (Sudafed) or placebo. They were evaluated two weeks later by tympanometry and (independently) by clinical evaluation and pneumotoscopy. There were no significant differences between the two groups, except that males developed SOM significantly more often than did females. Use of decongestant and placebo was continued in 78 patients with SOM for up to four more weeks. Again, there were no siginificant differences between the treatment groups except that patients with an allergic history did significantly worse using a decongestant. Overall there was no benefit from pseudoephedrine in either the prevention or treatment of SOM.

• Authors: A L Olson, S W Klein, E Charney, J B MacWhinney Jr, T K McInerny, R L Miller, L F Nazarian, D Cunningham
• Journal: Pediatrics (Pediatrics) Vol. 61 Issue 5 Pg. 679-84 (May 1978) ISSN: 0031-4005 [Print] United States
• PMID: 351537 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Placebos
• Ephedrine

Topics

• Acute Disease
• Administration, Oral
• Adolescent
• Air
• Child
• Child, Preschool
• Clinical Trials as Topic
• Double-Blind Method
• Endoscopy
• Ephedrine (administration & dosage, therapeutic use)
• Female
• Humans
• Male
• Otitis Media (diagnosis, drug therapy, prevention & control)
• Patient Compliance
• Placebos
• Serous Membrane